NEW YORK (GenomeWeb) – In a filing with US Securities and Exchange Commission today, CareDx said it has entered into an agreement with investment bank Jefferies to sell up to $50 million in shares of its common stock from time to time.

Jefferies, which is acting as CareDx's agent and underwriter in the sale, will be entitled to compensation at a commission rate of up to 3 percent of the gross sales price of the shares sold under the agreement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.